156 related articles for article (PubMed ID: 2660527)
21. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
Washida H; Sakagami H; Iwase Y; Sasaki S
Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
Kishi H; Kaneco H; Tominaga T; Niijima T; Nishimura Y; Saito I; Ishii Y; Nito H; Yuge J; Asano M
Hinyokika Kiyo; 1984 Jan; 30(1):103-20. PubMed ID: 6375317
[TBL] [Abstract][Full Text] [Related]
23. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
[TBL] [Abstract][Full Text] [Related]
25. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
Kawamura J; Hayashi N; Okabe S; Kawahara S; Chigusa I; Araki T; Saito K; Takeno K; Suzuki N; Suzuki I
Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
[TBL] [Abstract][Full Text] [Related]
26. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
[TBL] [Abstract][Full Text] [Related]
27. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of cefotetan in complicated urinary tract infections].
Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
[TBL] [Abstract][Full Text] [Related]
29. [Clinical evaluation of Claforan (CTX) in aged patients with chronic complicated urinary tract infections].
Washida H; Tsugaya M; Hirao N; Hachisuka Y
Hinyokika Kiyo; 1984 Jan; 30(1):121-9. PubMed ID: 6328960
[TBL] [Abstract][Full Text] [Related]
30. [Clinical trial of HAPA-B in complicated urinary tract infections].
Kamiryo Y; Kato M; Sanefuji T; Hirao H
Hinyokika Kiyo; 1986 Sep; 32(9):1379-85. PubMed ID: 3101447
[TBL] [Abstract][Full Text] [Related]
31. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A; Cortecchia V; Ventriglia L
Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
[No Abstract] [Full Text] [Related]
32. [Clinical experience with T-2588 in complicated urinary tract infections].
Fukatsu H; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y; Waki M; Takamura T; Hiraiwa S; Yamada Y; Muramatsu T
Hinyokika Kiyo; 1986 Jul; 32(7):1061-8. PubMed ID: 3776768
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].
Matsuda S; Oh K; Hirayama H; Shimizu T; Sengoku K; Haga H; Inoue R; Yamazaki T; Mizoguchi H; Tori-i Y
Jpn J Antibiot; 1990 Apr; 43(4):736-53. PubMed ID: 2199691
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
Tsuchida S; Sasaki S; Takada H; Miyagata S; Sato S; Shimizu S; Sakamoto F; Kizu N
Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
[TBL] [Abstract][Full Text] [Related]
36. [Clinical studies on enoxacin in urinary tract infection].
Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of ofloxacin in the treatment of chronic complicated urinary tract infection].
Uchibayashi T; Nishino A; Motoi I; Hisazumi H; Sawaki M; Orito M; Koizumi H; Shyoda R; Nagano K; Kobashi K
Hinyokika Kiyo; 1990 Jun; 36(6):725-30. PubMed ID: 2239569
[TBL] [Abstract][Full Text] [Related]
39. [Clinical studies on ceftriaxone in complicated urinary tract infections].
Yamakawa K; Hioki T; Kawamura J
Hinyokika Kiyo; 1989 Feb; 35(2):377-82. PubMed ID: 2735247
[TBL] [Abstract][Full Text] [Related]
40. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
